Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.
Kim MS, Lee JH, Kim EJ, Park DG, Park SJ, Park JJ, Shin MS, Yoo BS, Youn JC, Lee SE, Ihm SH, Jang SY, Jo SH, Cho JY, Cho HJ, Choi S, Choi JO, Han SW, Hwang KK, Jeon ES, Cho MC, Chae SC, Choi DJ. Kim MS, et al. Among authors: park jj, park sj, park dg. Korean Circ J. 2017 Sep;47(5):555-643. doi: 10.4070/kcj.2017.0009. Epub 2017 Sep 18. Korean Circ J. 2017. PMID: 28955381 Free PMC article. Review.
Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial.
Choi DJ, Park CS, Park JJ, Lee HY, Kang SM, Yoo BS, Jeon ES, Hong SK, Shin JH, Kim MA, Park DG, Kim EJ, Hong SJ, Kim SY, Kim JJ. Choi DJ, et al. Among authors: park cs, park jj, park dg. Trials. 2018 Feb 13;19(1):103. doi: 10.1186/s13063-018-2470-5. Trials. 2018. PMID: 29433525 Free PMC article.
Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter Study.
Park CS, Park JJ, Lee HY, Kang SM, Yoo BS, Jeon ES, Hong SK, Shin JH, Kim MA, Park DG, Kim EJ, Hong SJ, Kim SY, Kim JJ, Choi DJ. Park CS, et al. Among authors: park jj, park dg. Cardiovasc Drugs Ther. 2023 Jun;37(3):529-537. doi: 10.1007/s10557-021-07238-3. Epub 2022 Jan 23. Cardiovasc Drugs Ther. 2023. PMID: 35066737 Clinical Trial.
Correction: Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial.
Choi DJ, Park CS, Park JJ, Lee HY, Kang SM, Yoo BS, Jeon ES, Hong SK, Shin JH, Kim MA, Park DG, Kim EJ, Hong SJ, Kim SY, Kim JJ. Choi DJ, et al. Among authors: park cs, park jj, park dg. Trials. 2022 Jul 25;23(1):594. doi: 10.1186/s13063-022-06559-4. Trials. 2022. PMID: 35879804 Free PMC article. No abstract available.
A multicenter, eight-week treatment, single-step titration, open-label study assessing the percentage of Korean dyslipidemic patients achieving LDL cholesterol target with atorvastatin starting doses of 10 mg, 20 mg and 40 mg.
Lee CW, Baek SH, Hong TJ, Choi YJ, Kim YJ, Ahn TH, Ihm SH, Bae JH, Hong SJ, Kim DI, Ahn YK, Hur SH, Park DG, Choi DJ, Lee SU, Kim BS, Ryu KH, Jang YS, Lee SH, Seung KB, Kim HS. Lee CW, et al. Among authors: park dg. Cardiovasc Drugs Ther. 2010 Apr;24(2):181-8. doi: 10.1007/s10557-010-6225-0. Cardiovasc Drugs Ther. 2010. PMID: 20383571 Clinical Trial.
124 results